Evidence map›Paper›PMID 32837337›Full record

ReviewCurrent treatment options in infectious diseases2020

Barrier Precautions in the Era of Multidrug Pathogens.

Rachel Pryor, Carli Viola-Luqa, Olivia Hess, Gonzalo Bearman

Open access · bronzeAbstract readReview
In one paragraph

Review in Current treatment options in infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rachel PryorHospital Infection Prevention Program, Virginia Commonwealth University Health System, Richmond, VA USA.ORCID 0000-0001-9567-8778
Carli Viola-LuqaHospital Infection Prevention Program, Virginia Commonwealth University Health System, Richmond, VA USA.
Olivia HessHospital Infection Prevention Program, Virginia Commonwealth University Health System, Richmond, VA USA.
Gonzalo BearmanHospital Infection Prevention Program, Virginia Commonwealth University Health System, Richmond, VA USA.
Virginia Commonwealth University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose of review: There is a continuing debate regarding contact precaution (CP) usage for endemic multidrug-resistant organisms (MDROs). In this review, we examine current recommendations for CP and highlight differences in CP use between endemic and non-endemic MDROs. Recent findings: The discontinuation of CP had no effect on the incidence of methicillin-resistant Summary: Contact precautions are frequently part of a bundled infection control approach that involves meticulous hand hygiene, patient decolonization, chlorhexidine gluconate bathing, and reducing the use of invasive devices. Healthcare facilities should continue to utilize CP for non-endemic MDROs and the presence of endemic MDROs; however, CP may not add benefit to the current infection prevention bundle approach.

Indexed as

Contact precautionsControversyEndemicHigh-quality CPMDROs

Identifiers

PMID32837337
PMCPMC7323884
OpenAlexW3040581466

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.